Four papers with women, vaginal or menstrual in the title. One human trial, in 2022.
A 2022 trial used plasma-activated water spray for vaginal cleaning in patients with bacterial vaginosis, published in Medical Sciences (Basel) and open access. It is the first human trial of plasma-activated water ever published — the study that opened the entire clinical area.
Almost everything that should have followed it. Four years on, four papers. An area of health opened by one study and then left alone.
“The first ever human trial on plasma water was about women's health. Four years later there are four papers. Four.”
What would they want studied? The answers are content, and they're a real signal.
Under-researched women's health is a funding priority almost everywhere right now. This has a live case.
This is an extract. The full picture is in What Plasma Water Actually Does — or start at the library index.
Cold Plasma Research Library. Compiled from Europe PMC and ClinicalTrials.gov, September 2026 — 4,846 cold plasma papers, 662 on plasma-activated water, 52 registered trials. Counts are title-restricted and therefore floors, not ceilings: a low number means barely anyone has made this their subject, not that nobody has ever looked.
These pages describe published research on a technology. They do not describe or endorse any product, they are not medical advice, and nothing here should be used to decide about treating a health condition. Speak to a qualified clinician about anything that matters.